In the current global climate, several companies that previously made commercial goods are now joining the call to produce masks, ventilators and other medical devices in short supply. This article will focus on the current U.S. environment.

ACS 2023 -- Analytical methods used to support the registration of products have to be effective, robust and reliable, meeting a range of specific requirements, as demonstrated during the validation process.

ACS 2023 -- Analytical chemists often face hurdles in developing reliable residue methods due to a range of scientific challenges. These can typically include poor instrument response, poor stability, unfavourable chemical properties, lack of selectivity or the need to quantify at very low concentrations.

A surgical device manufacturer pursued their first 510(k) clearance for their CE-marked product but was faced with considerable challenges during the FDA review process.

Successfully developing a medical device or combination product in the preclinical stage requires the right resources and guidance combined with quality delivery and optimal scientific knowledge and capabilities.

Meet your regulatory obligations with high-quality data and expert insights.

Labcorp discovery oncology offers hundreds of cell line growth curves in our complete cell line list.

A mid-sized biotech sponsor developing novel autologous and allogeneic CAR T therapies engaged Labcorp to support several solid tumor and hematologic malignancy therapeutic programs.

From preclinical research through clinical development, we're here to help you at every stage of the continuum to deliver accurate, on-time results and advance your program. To meet your program's requirements, our GLP, nonproprietary methods have been developed according to FDA Crystal City and current regulatory guidelines.